Adenoviral pneumonia during etanercept treatment in a patient with rheumatoid arthritis

Min Jung Kang; Myung Sin Kim; Eun Hwa Choi; Kyoung Eun Lee; You Kyoung Kim; Hee Jung Choi

doi:10.3904/kjim.2007.22.1.63

Adenoviral pneumonia during etanercept treatment in a patient with rheumatoid arthritis

Min Jung Kang, Myung Sin Kim, Eun Hwa Choi, Kyoung Eun Lee, You Kyoung Kim, Hee Jung Choi

Department of Internal Medicine

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

Inhibitors of tumor necrosis factor-alpha (TNF-α) have been approved for treating rheumatoid arthritis. As one of the biological response modifiers, etanercept has also been used in the treatment of psoriatic arthritis and inflammatory bowel disease. While etanercept is effective, certain infectious complications, such as tuberculosis, fungus, and cytomegalovirus, have been reported. We report the first Korean case of adenoviral pneumonia in a 55-year-old female who developed disseminated adenoviral infection following etanercept treatment, which resolved after anti-TNF-α discontinuation.

Original language	English
Pages (from-to)	63-66
Number of pages	4
Journal	Korean Journal of Internal Medicine
Volume	22
Issue number	1
DOIs	https://doi.org/10.3904/kjim.2007.22.1.63
State	Published - 2007

Keywords

Adenovirus infections
Human
Pneumonia
TNFR-Fc fusion protein
Tumor necrosis factor-alpha

Access to Document

10.3904/kjim.2007.22.1.63

Cite this

@article{15e4fab39411430aa6dc07ee33e8f807,

title = "Adenoviral pneumonia during etanercept treatment in a patient with rheumatoid arthritis",

abstract = "Inhibitors of tumor necrosis factor-alpha (TNF-α) have been approved for treating rheumatoid arthritis. As one of the biological response modifiers, etanercept has also been used in the treatment of psoriatic arthritis and inflammatory bowel disease. While etanercept is effective, certain infectious complications, such as tuberculosis, fungus, and cytomegalovirus, have been reported. We report the first Korean case of adenoviral pneumonia in a 55-year-old female who developed disseminated adenoviral infection following etanercept treatment, which resolved after anti-TNF-α discontinuation.",

keywords = "Adenovirus infections, Human, Pneumonia, TNFR-Fc fusion protein, Tumor necrosis factor-alpha",

author = "Kang, {Min Jung} and Kim, {Myung Sin} and Choi, {Eun Hwa} and Lee, {Kyoung Eun} and Kim, {You Kyoung} and Choi, {Hee Jung}",

year = "2007",

doi = "10.3904/kjim.2007.22.1.63",

language = "English",

volume = "22",

pages = "63--66",

journal = "Korean Journal of Internal Medicine",

issn = "1226-3303",

publisher = "Korean Association of Internal Medicine",

number = "1",

}

TY - JOUR

T1 - Adenoviral pneumonia during etanercept treatment in a patient with rheumatoid arthritis

AU - Kang, Min Jung

AU - Kim, Myung Sin

AU - Choi, Eun Hwa

AU - Lee, Kyoung Eun

AU - Kim, You Kyoung

AU - Choi, Hee Jung

PY - 2007

Y1 - 2007

N2 - Inhibitors of tumor necrosis factor-alpha (TNF-α) have been approved for treating rheumatoid arthritis. As one of the biological response modifiers, etanercept has also been used in the treatment of psoriatic arthritis and inflammatory bowel disease. While etanercept is effective, certain infectious complications, such as tuberculosis, fungus, and cytomegalovirus, have been reported. We report the first Korean case of adenoviral pneumonia in a 55-year-old female who developed disseminated adenoviral infection following etanercept treatment, which resolved after anti-TNF-α discontinuation.

AB - Inhibitors of tumor necrosis factor-alpha (TNF-α) have been approved for treating rheumatoid arthritis. As one of the biological response modifiers, etanercept has also been used in the treatment of psoriatic arthritis and inflammatory bowel disease. While etanercept is effective, certain infectious complications, such as tuberculosis, fungus, and cytomegalovirus, have been reported. We report the first Korean case of adenoviral pneumonia in a 55-year-old female who developed disseminated adenoviral infection following etanercept treatment, which resolved after anti-TNF-α discontinuation.

KW - Adenovirus infections

KW - Human

KW - Pneumonia

KW - TNFR-Fc fusion protein

KW - Tumor necrosis factor-alpha

UR - http://www.scopus.com/inward/record.url?scp=34248576774&partnerID=8YFLogxK

U2 - 10.3904/kjim.2007.22.1.63

DO - 10.3904/kjim.2007.22.1.63

M3 - Article

C2 - 17427651

AN - SCOPUS:34248576774

SN - 1226-3303

VL - 22

SP - 63

EP - 66

JO - Korean Journal of Internal Medicine

JF - Korean Journal of Internal Medicine

IS - 1

ER -

Adenoviral pneumonia during etanercept treatment in a patient with rheumatoid arthritis

Abstract

Keywords

Access to Document

Fingerprint

Cite this